|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/861 | (2006.01) |
| C12N 15/864 | (2006.01) | ||
| C12N 7/04 | (2006.01) |
| (11) | Number of the document | 3436593 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17776462.8 |
| Date of filing the European patent application | 2017-03-28 | |
| (97) | Date of publication of the European application | 2019-02-06 |
| (45) | Date of publication and mention of the grant of the patent | 2022-11-23 |
| (46) | Date of publication of the claims translation | 2023-03-10 |
| (86) | Number | PCT/US2017/024545 |
| Date | 2017-03-28 |
| (87) | Number | WO 2017/172772 |
| Date | 2017-10-05 |
| (30) | Number | Date | Country code |
| 201662314116 P | 2016-03-28 | US |
| (72) |
MORRISON, Christopher, J. , US
MARATT, James, D. , US
|
| (73) |
Ultragenyx Pharmaceutical Inc. ,
60 Leveroni Court, Novato, CA 94949,
US
|
| (74) |
Aurelija ŠIDLAUSKIENĖ,
Dr. V. Šidlauskas ir partneriai, UAB, K. Būgos g. 29, LT-44326 Kaunas,
LT
|
| (54) | Adenoviruso šiluminio inaktyvavimo būdai |
| METHODS OF HEAT INACTIVATION OF ADENOVIRUS |
| Payment date | Validity (years) | Amount | |
| 2026-02-26 | 10 | 231.00 EUR |
| 2027-03-28 |